The decentralized, patient-centric platform for clinical trials
In the face of COVID-19, around 85% of all clinical trials have been delayed and on average, 30% of enrolled patients will abandon a trial prematurely. Climedo's DCT platform (Decentralized Clinical Trials) enables you to implement clinical trials in a patient-centric, flexible and decentralized manner – both during the pandemic and beyond.